Project: dRug dELIvery system for Enhanced targeting of glioblastoma multiForme (GBM)
| Acronym | RELIEF (Reference Number: 113670) |
| Duration | 01/07/2020 - 01/07/2024 |
| Project Topic | RELIEF results in a novel intravenous drug delivery system (DDS) validated for Glioblastoma Multiforme (GBM) treatment in animal models. This DDS-GBM can 1) selectively target GBM tumor cells including GBM stem cells; 2) cross the blood-brain tumor barrier (BBTB); and 3) decrease toxicity allowing long circulation times and accumulation of high API concentrations. The DDS consists of asymmetric liposomes encapsulating the API and is coated with functionality-enhancing peptides and ligands. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 12 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Abnoba GmbH | Coordinator | Germany |
| 2 | GLIOCURE SAS | Partner | France |
| 3 | Université d’Angers | Partner | France |
| 4 | Universiteit Utrecht | Partner | Netherlands |
| 5 | Uppsala Universitet | Partner | Sweden |